Insights from PLMA 2025: What the Private-Label Boom Means for Operators, Investors & the Middle Market

The 2025 PLMA Annual Private Label Trade Show made one thing unmistakably clear: private label is not only growing – it’s accelerating. For those of us advising companies in the consumer, manufacturing, and supply-chain sectors, the implications are far-reaching.

Below are the key themes and takeaways we at Westlake Securities are bringing back from this year’s event, thanks to our very own Matt Andersen, CEO, and Jon Schultz, Managing Director of CMO Services, who attended the show in Chicago.

1. Store Brands Have Entered Their Maturity Phase – and Their Growth Curve

PLMA reported that U.S. store-brand dollar sales reached $271 billion in 2024, up 3.9%, compared with just 1% growth for national brands. Unit sales show a similar story. This is no longer a cyclical shift; it is a structural redefinition of consumer loyalty and retailer strategy.

The implications for middle-market companies:

  • Retailers are expanding private-label assortments at a historic pace.
  • Suppliers, co-manufacturers, and ingredient providers are being pulled into higher-expectation partnerships.
  • Transaction interest is increasing across contract manufacturing, specialty ingredients, packaging, branded private label, and operational tech.

Private label is no longer a “value alternative.” It is a growth engine, and capital is moving accordingly.

2. Innovation and Operational Discipline Are Driving Competitive Separation

  • Innovation is accelerating. Consumers expect health, wellness, premium experiences, sustainability, and transparency, even in private label. What was once a “follower model” is now increasingly a “fast-follower + selective leader” model.
  • Operational alignment has become critical. Sessions on planning and ERP integration made a compelling point: fragmented spreadsheets, inaccurate lead times, and siloed workflows are constraining margins and capacity across the industry.

For companies preparing for capital raises, acquisitions, or strategic partnerships, the ability to demonstrate innovation capability and operational maturity is becoming a differentiator that buyers and investors scrutinize carefully.

 

 

3. Manufacturers Are Becoming Strategic Partners, Not Just Producers

A notable shift came through in the Beauty/Health/Wellness discussions: private-label manufacturers are now shaping consumer experiences, not just fulfilling them. This elevated role increases:

  • the strategic value of specialized co-manufacturers,
  • demand for vertically aligned partnerships, and
  • investor interest in suppliers possessing R&D, formulation, or category expertise.

The convergence of health, beauty, wellness, and functional consumer products is creating new cross-category opportunities for M&A and capital deployment.

4. What This Means for Companies in this Sector

Across categories, the message was consistent: private label’s growth is sustained, multi-category, and innovation-driven. We see several actionable implications:

  • Heightened buyer interest in contract manufacturers, specialty ingredient suppliers, private-label platforms, and retail-focused tech.
  • Valuation premiums for companies demonstrating strong operational discipline and scalable planning systems.
  • Increased strategic relevance for firms that can support retailer speed-to-market and innovation needs.
  • Continued consolidation opportunities, especially in fragmented manufacturing categories. 

Private label is riding a decade-long growth wave, and PLMA 2025 reinforced that this momentum is expanding, not slowing.

If you’d like to discuss how these trends may affect strategic planning, valuation, capital strategy, or M&A opportunities in your sector, we’d welcome the conversation.

Next Steps For CEOs